Health

Tags:

Omega-3s from fish oil supplements no better than placebo for dry eye

NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.

Omega-3 fatty acid supplements taken orally proved no better than placebo at relieving symptoms or signs of dry eye, according to the findings of a well-controlled trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. Dry eye disease occurs when the film that coats the eye no longer maintains a healthy ocular surface, which can lead to discomfort and visual impairment. The condition affects an estimated 14 percent of adults in the United States.

Tags:

Scientists teach computers how to analyze brain cells

NIH-funded researchers and Google show machine learning can be applied to biomedical research.

In the early days of neuroscience research, scientists painstakingly stained brain cells and drew by hand what they saw in a microscope. Fast forward to 2018 and machines may be able to learn how to do that work. According to a new study in Cell, it may be possible to teach machines how to pick out features in neurons and other cells that have not been stained or undergone other damaging treatments.

Tags:

NIH researchers crack mystery behind rare bone disorder

Study finds gene mutations that cause “dripping candle wax” bone disease.

20180411-melorheostosis-of-the-leg_0_0.jpg
An x-ray image of a patient with melorheostosis shows excess bone formation, likened to dripping candle wax.

Tags:

WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally

WHO and UNICEF issued new ten-step guidance to increase support for breastfeeding in health facilities that provide maternity and newborn services, on April 11th. Breastfeeding all babies for the first 2 years would save the lives of more than 820 000 children under age 5 annually.

Tags:

NIH study revises molecular classification for most common type of lymphoma

In a new study, researchers identified genetic subtypes of diffuse large B-cell lymphoma (DLBCL) that could help explain why some patients with the disease respond to treatment and others don’t. The study, led by researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI), part of the National Institutes of Health, with additional authors from several institutions around the world.

Tags:

WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally

BREASTFEEDING_2_0.jpg
A mother breastfeeding her newborn child at the Mother and Child Health Center in Bumbu, a district of Kinshasa, capital of the Democratic Republic of Congo, on October 20, 2017.

Tags:

Experts Warn Prescription, Over-the-Counter Drugs Polluting World's Rivers

The world's rivers and fresh water systems are full of pollution from prescription and over-the-counter drugs and it is taking a toll on the environment and wildlife, experts say.

Tags:

Nearly one billion people in Africa to be protected against yellow fever by 2026

yellow_fever(1)_0.jpg
There is no cure for Yellow Fever. It can only be prevented. A single dose of yellow fever vaccine is sufficient to give an individual life-long protection against the virus. Cunene Province, Angola 2016.

Tags:

Nearly one billion people in Africa to be protected against yellow fever by 2026

Nearly one billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from WHO, Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners.

Tags:

New biological research framework for Alzheimer’s to spur discovery

NIA, Alzheimer’s Association convene effort to update disease definition, speed testing.

The research community now has a new framework toward developing a biologically-based definition of Alzheimer’s disease. This proposed “biological construct” is based on measurable changes in the brain and is expected to facilitate better understanding of the disease process and the sequence of events that lead to cognitive impairment and dementia. With this construct, researchers can study Alzheimer’s, from its earliest biological underpinnings to outward signs of memory loss and other clinical symptoms, which could result in a more precise and faster approach to testing drug and other interventions.